Jon Talamo, M.D.

Jonathan H. Talamo, M.D. is internationally known as an experienced surgeon and thought leader in the ophthalmology field, particularly in the areas of corneal disease, cataract and refractive surgery. He serves as a consultant or board member to numerous companies in the biopharma, medical device and health care delivery sectors. Following 25 years in clinical practice, Dr. Talamo worked in executive operating roles as Chief Medical Officer at Ocular Therapeutix where he played an important role in the development of Dextenza (extended release dexamethasone ophthalmic insert) and, most recently, as Chief Medical Officer and Worldwide Vice President of Clinical and Medical Affairs at Johnson and Johnson Vision. While at Johnson and Johnson Vision, Dr. Talamo helped lead the integration of Abbott Medical Optics as well as the development and launch of numerous innovative products, including the Tecnis Toric 2, Synergy and Eyhance Intraocular Lenses, Acuvue Oasis with Transitions and iDesign 2.0.